.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Leishmaniases encompass a group of clinically distinct diseases caused by the protozoan parasite Leishmania. Infected sand flies transmit these parasites to humans through bites. For clinicians, understanding leishmaniasis diagnosis and treatment is vital, especially given the rising global cases of cutaneous forms. Furthermore, India has shown remarkable progress in reducing the burden of the visceral form, known as Kala-azar.
The disease manifests in three primary forms. Cutaneous leishmaniasis (CL) represents the most frequent presentation, typically appearing as localized skin ulcers. Moreover, the Eastern Mediterranean region currently reports increasing case numbers of this form. Mucosal leishmaniasis (ML) is more aggressive, causing destruction in the nose and throat. Visceral leishmaniasis (VL) remains life-threatening due to systemic dissemination to the blood and bone marrow.
Consequently, laboratory techniques have evolved significantly. Traditional microscopy is being replaced by molecular methods. Additionally, physicians use these tests to identify specific parasite species from tissue samples. This specificity ensures more targeted therapeutic choices for the patient. Therefore, molecular testing is now the gold standard in modern leishmaniasis diagnosis and treatment protocols.
Treating this infection remains difficult because of limited pharmacological options. However, the shift toward combination therapies for visceral leishmaniasis has significantly improved clinical outcomes. In India, the national program primarily utilizes single-dose liposomal amphotericin B. This strategy has successfully pushed the country toward elimination status. Furthermore, maintaining early diagnosis and vector control remains essential for long-term success.
Moreover, research into prevention is advancing rapidly. Two human vaccines are currently in the pipeline, with some ready for human trials. Until these become available, clinicians must rely on rapid molecular identification and optimized drug regimens. Regular surveillance and adherence to updated management protocols are critical for managing all forms of the disease.
Clinicians now prefer molecular methods over traditional microscopy. Furthermore, these techniques allow for species identification using tissue samples from the bone marrow or skin, which ensures higher diagnostic accuracy.
The primary challenges include a limited selection of effective drugs and the risk of parasitic resistance. Therefore, experts recommend using combination therapies and strictly following the latest clinical guidelines to optimize recovery.
Disclaimer: This content is for informational and educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A clinical update on leishmaniasis diagnosis and treatment, highlighting the shift to molecular methods and combination therapies in the Indian context....
3 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
